Successful treatment of multiresistant Achromobacter xylosoxidans bacteremia in a child with acute myeloid leukemia

Annals of Saudi Medicine

Volumn 35, Issue 2, 2015, Pages 168-169

  Tugcu, Deniz ^a   Turel, Ozden ^b   Aydogan, Gonul ^a   Akcay, Arzu ^a   Salcioglu, Zafer ^a   Akici, Ferhan ^a   Sen, Hulya ^a   Demirkaya, Metin ^a   Taskin, Necati ^a   Gurler, Nezahat ^c  

^a Kanuni Sultan Suleyman Public Hospital   (Turkey)

^b Kanuni Sultan Suleyman Education and Research Hospital   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; C REACTIVE PROTEIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; ANTIINFECTIVE AGENT; MINOCYCLINE; PENICILLANIC ACID; PIPERACILLIN; PIPERACILLIN, TAZOBACTAM DRUG COMBINATION;

ACHROMOBACTER XYLOSOXIDANS; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BLOOD CULTURE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; CHILDHOOD LEUKEMIA; COLOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DETERIORATION; DISK DIFFUSION; ECHOCARDIOGRAPHY; FEBRILE NEUTROPENIA; FEVER; FOLLOW UP; GRANULOCYTE TRANSFUSION; HUMAN; HYPEREMIA; LABORATORY TEST; LEUKEMIA REMISSION; MALE; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL COUNT; PERIANAL ABSCESS; PRIORITY JOURNAL; THORAX RADIOGRAPHY; ACHROMOBACTER DENITRIFICANS; ANALOGS AND DERIVATIVES; COMPLICATION; GRAM-NEGATIVE BACTERIAL INFECTIONS; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; NEUTROPENIA; PATHOLOGY;

ACHROMOBACTER DENITRIFICANS; ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, MYELOID, ACUTE; MALE; MINOCYCLINE; NEUTROPENIA; PENICILLANIC ACID; PIPERACILLIN;

EID: 84941638472     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.5144/0256-4947.2015.168     Document Type: Article

References (10)

1. Yabuuchi E, Yano I, Goto S, Tanimura E, Ito T, Ohyama A. Description of Achromobacter xylosoxidans Yabuuchi and Ohyama 1971. Int J system Bact 1974;24:470-7
2. Holmes B, Snell JJ, Lapage SP. Strains of Achromobacter xylosoxidans from clinical material. J Clin Pathol 1977;30:595-601
3. Duggan JM, Goldstein SJ, Chenoweth CE, Kauffman CA, Bradley SF. Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis 1996;23:569-76
4. Aisenberg G, Rolston KV, Safdar A. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003). Cancer 2004;101:2134-40
5. Gómez-Cerezo J, Suárez I, Ríos JJ, Peña P, García de Miguel MJ, de José M, et al. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis 2003;22:360-3
6. Decre D, Arlet G, Danglot C, Lucet JC, Fournier G, Bergogne-Bérézin E, et al. A beta lactamase-over producing strain of Alcaligenes denitrificans subsp. xylosoxidans isolated from a case of meningitis. J Antimicrob Chemother 1992;30:769-79
7. Saiman L, Chen Y, Tabibi S, San Gabriel P, Zhou J, Liu Z, et al. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. J Clin Microbiol 2001;39:3942-5
8. Teng SO, Ou TY, Hsieh YC, Lee WC, Lin YC, Lee WS. Complicated intra-abdominal infection caused by extended drug-resistant Achromobacter xylosoxidans. J Microbiol Immunol Infect 2009;42:176-80
9. Parkins MD, Elborn JS. Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management. J Antimicrob Chemother 2010;65:1853-61
10. Jacquier H, Le monnier A, Carbonelle E, Corvec S, Illiaquer M, Bille E, et al: Gmc Study Group. In vitro antimicrobial activity of "Last resort" antibiotics against unusual nonfermenting gram negative bacilli in clinical isolates. Microb Drug Resist 2012 Aug;18(4):396-401